Apixaban vs rivaroxaban in patients with atrial fibrillation

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1796卷 / 1期
关键词：
D O I：
10.1007/s40278-020-76294-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 7
相关论文
共 50 条
  • [1] Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation
    Gu, Hong-Qiu
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (13): : 1290 - 1290
  • [2] Safety of apixaban and rivaroxaban in patients with atrial fibrillation on hemodialysis
    Ito, Hiroshi
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 124 : 154 - 155
  • [3] Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation
    Ray, Wayne A.
    Chung, Cecilia P.
    Stein, C. Michael
    Smalley, Walter
    Zimmerman, Eli
    Dupont, William D.
    Hung, Adriana M.
    Daugherty, James R.
    Dickson, Alyson
    Murray, Katherine T.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (23): : 2395 - 2404
  • [4] Effectiveness and Safety of Apixaban Versus Rivaroxaban for Patients With Atrial Fibrillation
    不详
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 463 - 473
  • [5] Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation
    Rillig, Andreas
    Lin, Tina
    Plesman, Joaquina
    Heeger, Christian-H.
    Lemes, Christine
    Metzner, Andreas
    Mathew, Shibu
    Wissner, Erik
    Wohlmuth, Peter
    Ouyang, Feifan
    Kuck, Karl-Heinz
    Tilz, Roland Richard
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (02) : 147 - 153
  • [6] Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation
    Sjalander, Sara
    Sjogren, Vilhelm
    Renlund, Henrik
    Norrving, Bo
    Sjalander, Anders
    [J]. THROMBOSIS RESEARCH, 2018, 167 : 113 - 118
  • [7] Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data
    Aslan, Onur
    Yildirim, Sinan
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 948 - 957
  • [8] Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation
    McHorney, Colleen A.
    Peterson, Eric D.
    Laliberte, Francois
    Germain, Guillaume
    Nelson, Winnie W.
    Crivera, Concetta
    Schein, Jeffrey
    Lefebvre, Patrick
    [J]. CLINICAL THERAPEUTICS, 2016, 37 (11) : 2477 - 2488
  • [9] Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or Rivaroxaban
    Ray, Wayne A.
    Chung, Cecilia P.
    Stein, C. Michael
    Smalley, Walter
    Zimmerman, Eli
    Dupont, William D.
    Hung, Adriana M.
    Daugherty, James R.
    Dickson, Alyson
    Murray, Katherine T.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (18): : 1565 - 1575
  • [10] PHARMACOECONOMIC ANALYSIS OF DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION: COMPARISON WITH RIVAROXABAN OR APIXABAN
    Gay-Molina, J. G.
    Herran, S.
    Sorensen, S.
    Gonschior, A. K.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A115 - A115
12345